Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares adjuvant BEP (bleomycin, etoposide, cisplatin) versus carboplatin in Stage I seminomatous testicular cancer; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Blenoxane (bleomycin)
  • Platinol (cisplatin)
  • Toposar (Etoposide)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Testicular Neoplasms, Seminoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING